Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
Clinical trial NCT05069857 · RECRUITING
Trial details
- NCT number
- NCT05069857
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2024-08-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.